secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K/A
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001493152-25-027399
Event type: other
Sentiment:  negative
Materiality: 0.60
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs to effect 1-for-10 reverse stock split to maintain Nasdaq listing
-------------------------------------------------------------------------------

- Stockholders approved reverse stock split on Nov 24, 2025; board approved Nov 30, 2025.
- Certificate of Amendment filed Dec 2, 2025; split effective Dec 22, 2025 at 8:00 AM ET.
- After split, approximately 5,768,951 shares of common stock will be outstanding.
- No fractional shares; any fractional shares rounded up to whole share.
- Reverse split intended to increase per-share price to meet Nasdaq continued listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000149315225027399/0001493152-25-027399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000149315225027399/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer